devices - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Volume 16 Issue 1

Fighting Counterfeits in the Medical Devices Sector –A Step Beyond the EU MDR

The counterfeiting of health products is a serious and growing concern, and it has come at the forefront of the public mind in recent years with several strict regul...

15 April 2024 Volume 16 Issue 1 | Editorial Archive concern | Counterfeits

Continue Reading →

Volume 15 Issue 2

Effective Operations for Risk Reduction and Supply Chain Resilience

There is no denying that the market for injectable drug delivery devices is growing rapidly, with forecasts predicting an increase from $39.93 billion in 2022 to $43...

3 July 2023 Volume 15 Issue 2 chain | delivery

Continue Reading →

Volume 15 Issue 1

Connected Drug Delivery Device Development: Where Are We At?

The market for parenteral drug-device combination products has evolved rapidly over the last 15–20 years and is expected to grow at a CAGR of 24.3% in the next eight...

4 April 2023 Volume 15 Issue 1 data | delivery

Continue Reading →

Volume 15 Issue 1

Emerging Quality Considerations Across the Global LifeSciences Supply Chain

New waves of innovation in Life Sciences, and a redoubled effort by regulators around the world to maintain the highest standards of safety, are placing increased pr...

4 April 2023 Volume 15 Issue 1 automation | devices

Continue Reading →

News

Phillips-Medisize Creates a Manufacturing Center of Excellence for Connected Health and Drug Delivery Devices

Phillips-Medisize, a Molex company, announces its initial investment to expand the capabilities of the 380,000 square foot Molex Little Rock facility to include a FD...

7 December 2017 News biopharmaceutical | connected health

Continue Reading →

News

Phillips-Medisize Exhibits During DDL2017

Phillips-Medisize will exhibit at the Drug Delivery to the Lungs Conference, which is taking place at Edinburgh International Conference Center on December 6-8, 2017...

28 November 2017 News conference | devices

Continue Reading →